Jun 2026· Bioinform.· Vol 42· 0 citations· 21 references
Computer ScienceMedicine
TL;DR
DruGUI 2.0 is developed to facilitate the search for druggable sites while allowing for proteins’ conformational flexibility, and complements, and benefits from, the vast collection of protein sequence, structure, and dynamics analyses modules accessible in ProDy.
Abstract
Abstract Summary We introduce DruGUI 2.0, a drug discovery tool for assessing the druggability of proteins, integrated into the ProDy application programming interface (API). DruGUI 2.0 is developed to facilitate the search for druggable sites while allowing for proteins’ conformational flexibility. Simulations in explicit solvent, with an option to include membrane, are carried out in the presence of probe molecules selected from an expanded library of small molecules containing drug-like fragments. Druggable sites beyond orthosteric sites are identifiable, as well as the probes that show high affinity to bind to those sites. Characterization of the composition and position of the probes helps build pharmacophore models and estimate relative binding affinities. As a Python module with enhanced visualization features, DruGUI 2.0 complements, and benefits from, the vast collection of protein sequence, structure, and dynamics analyses modules accessible in ProDy. Case studies in the Supplemental Material showcase the utility of DruGUI 2.0 applied to both soluble targets and membrane proteins. Availability ProDy is open-sourced and freely available under MIT License from https://github.com/prody/ProDy. The code version of DruGUI 2.0 used for simulations is available on Zenodo : 10.5281/zenodo.20511357.
This chapter describes a structure-based computational approach to perform high-throughput ligand screens of chemical libraries using open-source software programs and illustrates this workflow with the enzymatic molecular target NAD(P)H:quinone oxidoreductase1 (NQO1), which is overexpressed in a number of human solid tumors.
Audrey G. Fikes, Melissa C. Srougi· Methods in molecular biology· 0 citations
The factor of hydration of a representative set of 65 evolutionarily and structurally unrelated human enzymes in a water environment is investigated, showing that the content of low-entropy water molecules (LEW) in the active sites of human enzymes is systematically higher than that in other areas of their surface, including inactive cavities.
S. Panasenko, V. Khorev, M. Petukhov· bioRxiv· 0 citations
Theoceptor method can be applied to X-ray crystallography- or cryo-electron microscopy-derived structures, can be applied equally to covalent and noncovalent binders, and can provide excellent predictions for the changes in activity between matched molecular pairs.
Nikeel Cull, Yixin He, Sylvia C. Kaempf et al.· Methods in molecular biology· 0 citations
P Pep2Mol is introduced, a diffusion-based generative model for 3D molecule design that targets orthosteric PPI sites by explicitly incorporating binding peptides or proteins as structural guidance, moving beyond conventional pocket-conditioned generation.
Rongting Yue, Zekun Yang, G. Seabra et al.· bioRxiv· 0 citations
A novel method named Perturbed Flow Matching (PFM), which significantly reduces sampling steps by leveraging a Flow Matching framework and introduces a unique perturbed conditional probability path design that incorporates pocket binding site information and atom type-coordinate coupled information to enhance molecular generation performance.
Focusing on ACE2, which is critical for SARS-CoV-2 infection, an ACE2 decoy was developed to achieve higher binding affinity than the wild-type ACE2 and it is elucidated how this ACE2 decoy binds to the spike protein.
J. Kishikawa· Yakugaku Zasshi-journal of T...· 0 citations